DISABLING NEUROLOGICAL COMPLICATIONS OF AMIODARONE
- 1 June 1985
- journal article
- case report
- Published by Wiley in Australian and New Zealand Journal of Medicine
- Vol. 15 (3), 300-304
- https://doi.org/10.1111/j.1445-5994.1985.tb04040.x
Abstract
Five patients developed neurological symptoms during treatment with amiodarone for intervals ranging between five and 40 months. In each case the daily maintenance dose did not exceed 600 mg. The neurological manifestations included gait ataxia, tremor, polyneuropathy, and myopathy. In all five patients, the neurological symptoms were severe and disabling. In one patient with a myopathy, there was no improvement after amiodarone was withdrawn. The neurological side effects of amiodarone may be disabling and are not always reversible with drug withdrawal. Neurological complications may arise during treatment with usual maintenance doses.Keywords
This publication has 12 references indexed in Scilit:
- Frequent neurologic toxicity associated with amiodarone therapyNeurology, 1984
- Efficacy and safety of long-term amiodarone in treatment of cardiac arrhythmias: Dosage experienceAmerican Heart Journal, 1983
- Adverse reactions during treatment with amiodarone hydrochloride.BMJ, 1983
- AMIODARONE THERAPY FOR LIFE THREATENING OR REFRACTORY CARDIAC ARRHYTHMIASAustralian and New Zealand Journal of Medicine, 1983
- Amiodarone neuropathyNeurology, 1983
- Side effects of long-term amiodarone therapy.Circulation, 1983
- Pneumonitis and pulmonary fibrosis associated with amiodarone treatment: a possible complication of a new antiarrhythmic drug.Circulation, 1982
- Clinical pharmacology and therapeutic applications of the antiarrhythmic agent, amiodaroneAmerican Heart Journal, 1981
- Neuromyopathy during chronic amiodarone treatmentZeitschrift für Neurologie, 1979
- AMIODARONE AND NEUROLOGICAL SIDE-EFFECTSThe Lancet, 1974